<html>
<head>PUBMED IDs for LGMD2H</head>
<body bgcolor='#C5F0F2'><h1>LGMD2H</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9634523/'>A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus.</a> June 23  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10069710/'>Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G.</a> March 9  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11556001/'>[LGMD2H].</a> September 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11665864/'>Dysferlin protein analysis in limb-girdle muscular dystrophies.</a> October 23  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11822024/'>Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene.</a> February 1  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14959561/'>Molecular bases of autosomal recessive limb-girdle muscular dystrophies.</a> February 13  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15316618/'>[Limb girdle muscular dystrophies].</a> August 19  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15580560/'>The most common mutation in FKRP causing limb girdle muscular dystrophy type 2I (LGMD2I) may have occurred only once and is present in Hutterites and other populations.</a> December 8  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15786463/'>Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H.</a> March 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16816390/'>The interaction of Piasy with Trim32, an E3-ubiquitin ligase mutated in limb-girdle muscular dystrophy type 2H, promotes Piasy degradation and regulates UVB-induced keratinocyte apoptosis through NFkappaB.</a> July 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17994549/'>Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.</a> November 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19303295/'>Use of SNP array analysis to identify a novel TRIM32 mutation in limb-girdle muscular dystrophy type 2H.</a> July 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19349376/'>TRIM32 is an E3 ubiquitin ligase for dysbindin.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19492423/'>Intragenic deletion of TRIM32 in compound heterozygotes with sarcotubular myopathy/LGMD2H.</a> November 18  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21496629/'>Limb-girdle muscular dystrophy 2H and the role of TRIM32.</a> July 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21775502/'>The common missense mutation D489N in TRIM32 causing limb girdle muscular dystrophy 2H leads to loss of the mutated protein in knock-in mice resulting in a Trim32-null phenotype.</a> January 24  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23541687/'>A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation.</a> February 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23541686/'>Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24843229/'>Genetic basis of limb-girdle muscular dystrophies: the 2014 update.</a> August 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25351777/'>Detection of TRIM32 deletions in LGMD patients analyzed by a combined strategy of CGH array and massively parallel sequencing.</a> April 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25351766/'>BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis.</a> March 24  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25351745/'>MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking.</a> January 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25351743/'>Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.</a> September 22  2014<br></body></html>
